Global Health Update: Key Developments from WHO and Major Pharma News

This material covers the latest health news including WHO's call for $135 million to stop the mpox outbreak, the first recorded case in Gabon, free COVID-19 tests in the US, Johnson & Johnson's talc settlement talks, and WHO enabling vaccine purchases. Other significant updates include FDA recalls and potential Medicare drug listings.

Current health news highlights significant events including WHO's urgent appeal for $135 million to combat mpox, now recorded in Gabon. This comes as the US launches a fall campaign offering free COVID-19 tests. Johnson & Johnson is also negotiating a $6.48 billion talc settlement following court rejections.

WHO partners like Gavi can now purchase mpox vaccines early to expedite Africa's response to the virus. Additionally, the US FDA has issued a 'most serious' recall for Inari Medical's ClotTriever catheter. In future Medicare negotiations, drugs like Novo Nordisk's Ozempic are prime candidates, analysts predict. Uganda's mpox case count rises, and Africa anticipates its first mpox vaccines soon.

Furthermore, Novartis has received a significant acquisition offer from Siemens Healthineers for its molecular imaging business. These developments underscore ongoing challenges and responses in global health.

(With inputs from agencies.)